Holen Sie sich die Stockscreener-App
3.30
2.08%
-0.07
Handel nachbörslich:
3.52
0.22
+6.67%
Finanzdaten der Prelude Therapeutics Inc-Aktie (PRLD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
13.23%
5.64
|
6.50 | - | - | 4.00 |
Operating Expenses
|
14.60%
22.99
|
26.92 | 32.19 | 34.61 | 37.83 |
| Benefits Costs and Expenses |
22.10
|
- | - | - | 32.73 |
| Costs And Expenses |
17.91%
22.10
|
26.92 | - | - | 32.73 |
| Operating Income/Loss |
15.04%
-17.35
|
-20.42 | -32.19 | -34.61 | -33.83 |
| Income/Loss From Continuing Operations Before Tax |
353.18%
-16.46
|
6.50 | -31.23 | -32.09 | -28.73 |
| Income/Loss From Continuing Operations After Tax |
16.57%
-16.46
|
-19.73 | -31.23 | -32.09 | -28.73 |
|
Net Income/Loss
|
16.57%
-16.46
|
-19.73 | -31.23 | -32.09 | -28.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
98.79%
0.9181
|
76.13 | 75.99 | 75.99 | 0.0209 |
| Diluted Average Shares |
98.79%
0.9181
|
76.13 | 75.99 | 75.99 | 0.0209 |
| Basic Earnings Per Share |
23.08%
-0.20
|
-0.26 | -0.41 | -0.42 | -0.38 |
| Diluted Earnings Per Share |
23.08%
-0.20
|
-0.26 | -0.41 | -0.42 | -0.38 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):